The National Vaccine Injury Compensation Program (NVICP) was created by Congress as a no-fault alternative to the traditional tort system for resolving vaccine injury claims.
Congress established the National Vaccine Injury Compensation Program for two reasons:
- To protect the nation’s vaccine supply (by reducing lawsuits against manufacturers), and
- To compensate individuals injured by vaccinations.
Any person who is injured from a vaccine must first file a claim in the Vaccine Program, and cannot bring lawsuits against vaccine manufacturers or administrators of vaccines before filing in the Vaccine Program.
To be eligible to file a claim, the effects of the person’s injury must have:
- Lasted for more than six (6) months, or
- Resulted in a surgical intervention during an inpatient hospitalization, or
- Resulted in death.
Vaccines covered under NVICP include:
- Diphtheria, pertussis, tetanus (DTP, DTaP, Tdap, DT, Td, or TT)
- Haemophilus influenzae type b (Hib)
- Hepatitis A (HAV)
- Hepatitis B (HBV)
- Seasonal Influenza (Flu) Vaccine
- Measles-mumps-rubella (MMR, MR, M, R)
- Meningococcal (conjugate & polysaccharide) (MCV4, MPSV4)
- Polio (IPV, OPV)
- Pneumococcal conjugate (PCV)
- Rotovirus (RV)
- Varicella (VZV)
- Human Papillomavirus (HPV)
- Any combination of above vaccines